drug

GB-0895

1 story · latest Aug 6, 2026

Status: Investigational
Trials: 2 registered trials in coverage

Relationships

Developed by Generate Biomedicines

Timeline

Generate Biomedicines reports Q2 2026 results, advances asthma and oncology pipeline

Aug 6Quarterly updateGenerate Biomedicines

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.